{
  "content": "atrial fibrillation; Summary of findings 6 Amiodarone compared to placebo or no treatment for maintaining sinus rhythm after cardioversion of atrial fibrillation; Summary of findings 7 Dofetilide compared to placebo or no treatment for maintaining sinus rhythm after cardioversion of atrial fibrillation; Summary of findings 8 Dronedarone compared to placebo or no treatment for maintaining sinus rhythm after cardioversion of atrial fibrillation; Summary of findings 9 Sotalol compared to placebo or no treatment for maintaining sinus rhythm after cardioversion of atrial fibrillation",
  "source": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005049.pub5/abstract",
  "chunk_id": "e7dcd9c2-0768-48a0-9cb2-d991c451420a",
  "similarity_score": 0.3609030246734619,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 49,
  "title": "Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation",
  "authors": "Lucie Valembois, Etienne Audureau, Andrea Takeda, Witold Jarzebowski, Joël Belmin, Carmelo Lafuente‐Lafuente",
  "year": "2019",
  "journal": "Cochrane Database of Systematic Reviews",
  "reference": "Valembois, L., Audureau, E., Takeda, A., Jarzebowski, W., Belmin, J., & Lafuente-Lafuente, C. (2019). Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD005049.pub4",
  "doi": "10.1002/14651858.CD005049.pub4",
  "chunk_index": 128,
  "total_chunks": 370,
  "retrieved_at": "2025-07-24T21:58:13.326414"
}